Oragenics (OGEN) Current Deferred Revenue (2010 - 2016)
Oragenics (OGEN) reported Current Deferred Revenue of $17,687 for Q1 2016, up 2.4% from $17,276 a year earlier and up 24.4% from the prior quarter.
Powered by 
Analysis
Oragenics (OGEN) Current Deferred Revenue (2010 - 2016) Analysis & Trends
At the end of FY2015, Oragenics posted Current Deferred Revenue of $14,215, down 33.0% from FY2014.
- Current Deferred Revenue has a five-year compound annual growth rate of 1.5% (FY2010 to FY2015).
- By year, Current Deferred Revenue came in at $21,222 in FY2014 (+12.6%), $18,839 in FY2013 (-63.1%), $50,989 in FY2012 (-66.7%) and $152,962 in FY2011.
- Five-year quarterly Current Deferred Revenue spans a low of $14,215 in Q4 2015 and a high of $161,385 in Q3 2011.
- Year over year, Current Deferred Revenue gained in four of the last eight quarters, with an average decline of 12.7%.
- The high point for year-over-year Current Deferred Revenue in five years was Q2 2014 (growth of 68.0%); the low point was Q4 2012 (a decline of 66.7%).
- Per Business Quant data, the three quarters before Q1 2016 came in at $14,215 (Q4 2015), $15,339 (Q3 2015) and $17,855 (Q2 2015).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Oragenics | 2.12 Mn | 2.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2016 | 17,687.00 |
| Dec 31, 2015 | 14,215.00 |
| Sep 30, 2015 | 15,339.00 |
| Jun 30, 2015 | 17,855.00 |
| Mar 31, 2015 | 17,276.00 |
| Dec 31, 2014 | 21,222.00 |
| Sep 30, 2014 | 25,592.00 |
| Jun 30, 2014 | 38,876.00 |
| Mar 31, 2014 | 50,400.00 |
| Dec 31, 2013 | 18,839.00 |
| Sep 30, 2013 | 23,711.00 |
| Jun 30, 2013 | 23,147.00 |
| Dec 31, 2012 | 50,989.00 |
| Mar 31, 2012 | 145,196.00 |
| Dec 31, 2011 | 152,962.00 |
| Sep 30, 2011 | 161,385.00 |
| Jun 30, 2011 | 115,594.00 |
| Dec 31, 2010 | 13,188.00 |
API Access
Oragenics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=OGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "OGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=OGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();